Filing Details

Accession Number:
0001641172-25-005860
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-04-23 16:35:16
Reporting Period:
2025-04-21
Filing Date:
2025-04-23
Accepted Time:
2025-04-23 16:35:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
946644 Aim Immunotech Inc. AIM Biological Products, (No Disgnostic Substances) (2836) 520845822
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1187524 D Ted Kellner C/O T&Amp;M Partners, 790 N. Water St. #2175
Milwaukee, WI 53202
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2025-04-11 1,968,504 $0.03 1,969,504 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,456,000 Indirect By Kelvest I LP
Common Stock 270,000 Indirect By Beta Fund Investment Club
Common Stock 25,000 Indirect By Kellner, Ted Combined Profit Sharing/Money Purchase Plan
Footnotes
  1. Shares purchased pursuant to a purchase agreement executed on April 11, 2025, but first required approval from the NYSE American which was received on April 21, 2025.
  2. Shares held by Kelvest I LP, for which the reporting person serves as Manager of T&M Partners LLC, General Partner of Kelvest I LP.
  3. Shares held by the Beta Fund Investment Club, for which the reporting person serves as the manager and is an investor. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
  4. Shares held by the Kellner, Ted Combined Profit Sharing/Money Purchase Plan, for which the reporting person serves as trustee.
  5. Amends prior Form 3 filed by the reporting person with the SEC on 12/23/2024 due to a restructuring of family entities effective April 1, 2025. The reporting person is beneficial owner due to his role as Manager of T&M Partners LLC which serves as General Partner of a newly formed pooled investment vehicle that controls shares of the Company not previously reported on Form 3."